Status:
RECRUITING
Fecal Calprotectin for Prediction of Esophageal Varices in Cirrhotic Patients
Lead Sponsor:
Tanta University
Conditions:
Esophageal Varices
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this cross-sectional observational study is to evaluate the accuracy of fecal calprotectin versus non-invasive scores in assessing the presence and grading of esophageal varices in Egyptia...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Liver cirrhosis
Exclusion
- Patients aged \< 18 years.
- Inflammatory bowel disease.
- Infectious gastroenteritis.
- Malignancy.
- Patients on proton pump inhibitors or NSAID.
- Patients with spontaneous bacterial peritonitis.
- Patients with hepatic encephalopathy.
- Unwilling to participate in our study.
Key Trial Info
Start Date :
December 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT06908798
Start Date
December 1 2024
End Date
December 1 2025
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University Hospitals
Tanta, Gharbyea, Egypt, 31516